Company / Capital Expenditures
PANACEA LIFE SCIENCES HOLDINGS, INC. Capital Expenditures History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$65.3K
FY2023
5-year range
$65.3K / $3.2M
FY2019-FY2023
Trend
-73.2%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 8 years, ranging from -$1,292 in FY2016 to $3M in FY2020.
Based on SEC 10-K filings.
$65,322 in FY2023 with a 3-year CAGR of -72.7%.
Declined from $162,946 to $65,322 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -72.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -72.7%, indicating a declining trend.
- In FY2023, capital expenditures decreased 73.2% year-over-year.
- Peak capital expenditures was recorded in FY2020.
- Lowest capital expenditures in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -3.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $65.3K | -73.2% |
| FY2022 | $243.8K | +49.6% |
| FY2021 | $162.9K | -94.9% |
| FY2020 | $3.2M | +491.3% |
| FY2019 | $541.2K | - |
| FY2018 | $0 | - |
| FY2017 | - | - |
| FY2016 | -$1.3K | - |
| FY2015 | $0 | - |
As of FY2023 · SEC Form 10-K · Last checked Jun 29, 2026